In summary, our results from the Western blot and the electrophysiological MEA-experiments provide evidence that the MAO inhibitor NM rescues the expression of the GABAA receptor-stabilizing protein ubqln1 during pharmacologically induced in vitro epilepsy in the hippocampus and neocortex. Here, UBQLN1 is linked to epilepsy.